VTVT - vTv Therapeutics Inc.
32.76
-2.090 -6.380%
Share volume: 129,106
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$34.85
-2.09
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-20-2025 | 05-15-2025 | 08-12-2025 | 11-06-2025 | |
| Assets | ||||||||
| Total Assets | 54.183 M | 46.458 M | 43.164 M | 38.266 M | 32.027 M | 26.448 M | 99.494 M | |
| Current Assets | 53.872 M | 46.200 M | 42.958 M | 38.113 M | 31.916 M | 26.374 M | 99.456 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 65.000 K | 65.000 K | 85.000 K | 85.000 K | 115.000 K | 93.000 K | 112.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 52.255 M | 45.526 M | 41.571 M | 36.746 M | 31.059 M | 25.922 M | 98.504 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 95.000 K | 72.000 K | 50.000 K | 28.000 K | 19.000 K | 16.000 K | 14.000 K | |
| Other Assets | 216.000 K | 186.000 K | 156.000 K | 125.000 K | 92.000 K | 58.000 K | 24.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 54.183 M | 46.458 M | 43.164 M | 38.266 M | 32.027 M | 26.448 M | 99.494 M | |
| Total liabilities | 28.196 M | 26.021 M | 25.251 M | 23.965 M | 23.130 M | 24.043 M | 28.951 M | |
| Total current liabilities | 8.921 M | 6.985 M | 6.424 M | 5.196 M | 4.316 M | 5.295 M | 10.163 M | |
| Accounts Payable | 8.731 M | 6.791 M | 6.226 M | 5.027 M | 4.191 M | 5.216 M | 9.803 M | |
| Other liabilities | 606.000 K | 367.000 K | 158.000 K | 100.000 K | 145.000 K | 79.000 K | 119.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 606.000 K | 367.000 K | 158.000 K | 100.000 K | 145.000 K | 79.000 K | 119.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 20.796 M | 16.475 M | 15.008 M | 12.199 M | 7.920 M | 2.762 M | 70.543 M | |
| Common stock | 306.917 M | 307.776 M | 311.092 M | 311.917 M | 312.730 M | 313.618 M | 390.097 M | |
| Retained earnings | -286.121 M | -291.301 M | -296.084 M | -299.718 M | -304.810 M | -310.856 M | -319.554 M |